Adviser
Leerink Partners.
Financial adviser, Fairness opinion on 9 live deals, from 9 Jun 2025 to 1 Jun 2026.
09Live deals
04Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 1 Jun 2026 | Avenzo / Rallybio | Agreement signed |
| Healthcare |
| 27 Apr 2026 | XOMA Royalty Corporation / Generation Bio | Closed |
| Healthcare |
| 29 Dec 2025 | Gilead Sciences, Inc. / Repare Therapeutics Inc. | Agreement signed |
| Healthcare |
| 18 Aug 2025 | XRA 4 Corp. / HilleVax | Agreement signed |
| Healthcare |
| 11 Aug 2025 | XOMA Royalty / Turnstone | Closed |
| Not stated |
| 13 Jul 2025 | Xeno Acquisition Corp. / ESSA Pharma Inc. | Agreement signed |
| Healthcare |
| 1 Jul 2025 | TuHURA Biosciences, Inc. / Kineta, Inc. | Closed |
| Healthcare |
| 20 Jun 2025 | Concentra Biosciences, LLC / Kronos Bio, Inc. | Closed |
| Not stated |
| 9 Jun 2025 | Ikena / Inmagene | Agreement signed |
| Healthcare |
By year, sector and stage
| 2026 | 2 |
|---|---|
| 2025 | 7 |
| Healthcare | 7 |
|---|---|
| Not stated | 2 |
| Agreement signed | 5 |
|---|---|
| Closed | 4 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Cooley LLP | 2 | 0 | 2 |
| Citizens | 1 | 1 | 0 |
| Evercore | 1 | 1 | 0 |
| Ropes & Gray LLP | 1 | 1 | 0 |